Related Experiment Video

Updated: Feb 7, 2026

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)
09:05

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Published on: June 12, 2017

30.9K

[Proinflammatory state in obese children]

M C Luciardi1, T R Carrizo1, E I Díaz1

  • 1Facultad de Bioquímica, Universidad Nacional de Tucumán, Argentina.

Revista Chilena De Pediatria
|July 13, 2018
PubMed

Insights

Obese children show higher levels of inflammatory markers like soluble CD40 ligand (sCD40L) and monocyte chemoattractant protein 1 (MCP-1). These elevated markers indicate low-grade inflammation linked to childhood obesity.

Area of Science:

  • Pediatric Endocrinology
  • Immunology
  • Metabolic Disorders

Background:

  • Obesity is a chronic disease in children linked to insulin resistance, type 2 diabetes, and cardiovascular issues.
  • Adipose tissue in obese individuals releases pro-inflammatory molecules, potentially driving atherosclerosis.
  • Low-grade inflammation is a key concern in pediatric obesity.

Purpose of the Study:

  • To compare serum levels of specific inflammatory markers in obese children versus a control group.
  • To investigate the relationship between these inflammatory markers and anthropometric/metabolic variables in obese children.

Main Methods:

  • A cross-sectional observational study involving 37 obese children and 20 normal-weight children (ages 8-12).
  • Serum levels of soluble CD40 ligand (sCD40L), MCP-1, IL-6, TNF-α, and hsCRP were measured.
  • Spearman correlation was used to analyze relationships between variables.

Main Results:

  • Obese children exhibited significantly higher serum levels of sCD40L, MCP-1, IL-6, TNF-α, and hsCRP compared to controls.
  • Body mass index and waist circumference showed positive correlations with sCD40L and MCP-1 levels.

Conclusions:

  • Elevated levels of the studied inflammatory molecules suggest an association with low-grade inflammation in obese children.
  • These findings highlight potential inflammatory pathways involved in pediatric obesity and its complications.
Abstract

More Related Videos

Eye Tracking Young Children with Autism09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

46.6K
Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
309
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
287
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.6K